Insulet
| Year |
|---|
| Jan |
|---|
| Feb |
|---|
| Mar |
|---|
| Apr |
|---|
| May |
|---|
| Jun |
|---|
| Jul |
|---|
| Aug |
|---|
| Sept |
|---|
| Oct |
|---|
| Nov |
|---|
| Dec |
|---|
| Year |
|---|
| 2026 | ▼ 10.0% | ▼ 3.6% | ▼ 14.9% | ▼ 18.0% | ▼ 15.8% | ▲ 5.0% | ▲ 8.6% | ▼ 10.1% | ▼ 12.2% | ▲ 14.7% | ▲ 3.5% | ▼ 45.5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ▼ 13.1% |
From our own closes, each month-end against the previous month-end. Colour saturates at ▲ 15.8%; an empty cell means no data, a dash means we declined to derive one.
Fiscal period: FY · 2025-12-31 (10-K) — annual data, not TTM · USD · Source: SEC EDGAR (public domain)
Balance-sheet lines and ratios (assets, equity, ROE, ROA, net margin, debt/equity) open on the paid plans. See the plans